MIT Horizon spotlights Controlant
In a recent interview with MIT Horizon, Erlingur Brynjúlfsson, Chief Strategy Officer and co-founder, sheds light on how Controlant’s real-time monitoring solutions enable the safe, efficient, and sustainable delivery of medicines and vaccines while eliminating waste and ensuring patient safety.
Sign up for the Controlant newsletter
Keep up with developments in pharma supply chain visibility. Sign up for Controlant Insights and receive our latest white paper.
Erlingur highlights that the “consistent flow of high-quality data“ is key in driving decision-making in pharma supply chains to prevent waste and ensure patient safety.
The article covers Controlant’s role in supporting the delivery of more than 6 billion Covid-19 vaccine doses to global destinations, and the company’s vision of enabling zero-waste pharma supply chains in collaboration with the world’s leading pharmaceutical companies and logistics service providers.
MIT Horizon offers an exclusive library, events, and workshops that provide the continuous learning a global workforce needs to understand and leverage today's innovations.
Read the full case study
